Galera says mergers set to close Aug. 3, 2026

PUBT · 2d ago
Galera says mergers set to close Aug. 3, 2026
  • Galera Therapeutics’ pending mergers are expected to close on Aug. 3, 2026, subject to customary closing conditions.
  • Stockholders will receive a pre-closing distribution of contingent value rights tied to proceeds from monetizing tilarganine and GC4711, GC4419 programs.
  • Record date set for July 31, 2026; distribution expected on Aug. 6, 2026, three business days after the effective time.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Galera Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-328716), on July 31, 2026, and is solely responsible for the information contained therein.